Expert Report: Maximizing Innovation—The Connecticut R&D Tax Credit and the Interplay of DECD and DRS

The Connecticut Department of Economic and Community Development (DECD) coordinates major capital investment incentives for companies with stranded tax assets, facilitating economic growth and job creation, while the Department of Revenue Services (DRS) administers the state’s core R&D tax credits, which feature highly favorable incremental (20%) and non-incremental (1-6%) rate structures.

Connecticut operates a sophisticated dual-track system for incentivizing corporate research and development expenditures. This structure deliberately separates statutory compliance and collection (the DRS’s mandate) from large-scale, performance-based economic utilization and incentive allocation (the DECD’s mandate). The result is a highly competitive tax regime that not only offers generous annual credits but also provides a distinct mechanism for mobilizing accumulated, unused tax assets to fund significant state-level economic development projects. This report provides a definitive guide to navigating the legal framework, procedural requirements, and financial mechanics governing these incentives for strategic tax and business planning.

I. Strategic Oversight: The Department of Economic and Community Development (DECD) in Context

A. DECD’s Core Mission and Business Incentives

The Department of Economic and Community Development (DECD) serves as Connecticut’s central body for coordinating economic growth, focusing on job creation and strategic capital deployment, thereby fulfilling an objective distinct from the purely revenue-collecting function of the Department of Revenue Services (DRS). DECD’s programs are strategically structured to convert state tax policies into active, performance-based economic incentives. For instance, participation in certain DECD-managed programs requires applicants to meet specific, predetermined growth metrics related to employment or capital investment.1

B. The Accumulated Tax Credit Expansion Program (ATCEP): DECD’s Direct Involvement

The most direct intersection between the DECD and R&D tax policy is through the Accumulated Tax Credit Expansion Program (ATCEP).1 This program was established to provide essential liquidity for R&D credits that are often described as “stranded” or “unutilized” on a company’s balance sheet, thereby preventing them from becoming perpetual, illiquid liabilities.

1. Program Goal and Eligibility Criteria

To be considered for the ATCEP, a business must first demonstrate a significant accumulation of unused tax assets. Specifically, the business must have more than $500,000 of Connecticut R&D tax credits currently reflected on its balance sheet for which the company does not anticipate the ability to utilize them within the next two years.1 This requirement effectively focuses the program on established firms that have historically invested heavily in R&D but have reached their annual utilization caps. In addition to the credit threshold, the applicant must meet basic operational requirements, including being located in Connecticut and employing more than 10 people.1

2. Job Creation and Capital Expenditure Requirements

The application for ATCEP necessitates a verifiable commitment to future economic activity in Connecticut. The plan submitted to DECD must be comprehensive, detailing how the project utilizes the tax credit liquidity to meet at least one of two high-impact criteria 1:

1. Generate a minimum of 50 new jobs in Connecticut.1
2. Require capital expenditures of $5 million or greater.1

The policy structure reveals a nuanced understanding of economic policy: the DECD’s ATCEP transforms a passive tax asset (stranded credits) into an active negotiated subsidy. By demanding a minimum $5 million capital investment or the creation of 50 new jobs, the state ensures that unlocking the liquidity of the tax credit yields a tangible, immediate public economic benefit, justifying the state’s support of the utilization of previously dormant credits. This program, therefore, functions as a highly targeted tool for the recruitment and retention of highly capitalized R&D firms.

3. Joint Review Process (DECD and DRS Collaboration)

The ATCEP application process mandates intensive cooperation between the Department of Economic and Community Development and the Department of Revenue Services.1

• DECD Role: The DECD conducts the primary evaluation of the business and its growth potential. Their review focuses intensely on the completed application, the five-year growth plan, detailed budgets for operating expenses and capital expenditures, anticipated employee growth over the plan period (including expected annual salary and benefits), and the expected outcomes of the investment.1 The DECD determines the overall economic viability and adherence to the state’s strategic growth goals.2
• DRS Role: The DRS’s involvement is critical for regulatory validation. The DRS is responsible for the independent verification of the level of qualified accumulated credits that the company is requesting to utilize.1 This regulatory review includes requiring the applicant to present a Letter of Good Standing from the DRS, confirming the taxpayer’s compliance and regulatory status.2

The requirement for DRS verification of “the level of qualified accumulated credits” highlights the importance of rigorous audit-ready documentation even for past tax filings. The utilization of these credits, years after they were first earned, subjects the original R&D claim documentation to renewed, intense scrutiny by the state revenue office.

Table: DECD Accumulated Tax Credit Expansion Program (ATCEP) Requirements

II. Regulatory Architecture: Guidance from the Department of Revenue Services (DRS)

The core function of administering and regulating the R&D tax credits rests squarely with the Department of Revenue Services (DRS). The DRS ensures compliance with the state’s General Statutes and publishes necessary guidance for taxpayers.

A. Statutory Authority: Connecticut General Statutes (CGS)

The Connecticut R&D incentives are structured as two distinct tax credits applied against the Corporation Business Tax (Chapter 208).3 These dual credits allow businesses to choose the methodology that maximizes their benefit in any given year:

1. The Research and Experimental Expenditures Tax Credit (RC Credit): This is the incremental credit, codified under CGS § 12-217j.4 It rewards growth in spending year-over-year.
2. The Research and Development Expenses Tax Credit (RDC Credit): This is the non-incremental credit, codified under CGS § 12-217n.4 It rewards total annual spending based on tiered percentages.

Both credits define Qualified Expenses by reference to federal standards. Specifically, qualified expenses align with those deductible under IRC §174, as amended, and basic research payments as defined under IRC §41.3 A critical technical distinction exists for the non-incremental credit (RDC), which references expenses defined under IRC §174, as in effect on May 28, 1993.5 This historical alignment is a vital compliance detail, particularly following federal tax law changes, such as the mandatory capitalization of R&D expenses introduced at the federal level in 2022. Because Connecticut’s non-incremental credit definition is locked to the 1993 federal law, state R&D compliance may deviate significantly from current federal QRE definitions, requiring separate, specific state-level tracking and documentation for QREs.

B. Essential DRS Publications and Compliance Requirements

To guide taxpayers, the DRS maintains and regularly updates comprehensive publications, available through the Corporation Credit Guide.6 Key regulatory publications reflecting utilization caps, carryforwards, and other legislative changes were updated in March 2022 6:

• Research and Development Nonincremental Expenses 22MAR2022.6
• Research and Experimental (Incremental) Expenditures Tax Credit 22MAR2022.6

The existence of separate publications updated on the same day suggests that significant regulatory clarification or statutory changes were implemented concurrently, likely relating to the improved carryforward rules and utilization limits effective for tax years beginning on or after January 1, 2021.3

For filing, businesses must submit Form CT-1120 RDC, “Research and Development Expenditures Tax Credit,” to the DRS.9 It is mandatory to attach detailed schedules identifying the type, amount, and specific Connecticut location where the R&D expenses were incurred.9

III. Mechanism 1: Research and Experimental Expenditures Tax Credit (The Incremental RC Credit)

A. The 20% Incentive: Detailed Calculation Methodology

The Incremental RC Credit (CGS § 12-217j) is explicitly designed to reward corporations for demonstrating year-over-year growth in R&D investment, offering a substantial return on new spending.10

The methodology is straightforward and highly attractive: the credit equals 20% of the excess of the qualified research and experimental expenditures conducted in Connecticut during the current income year over the amount spent on such expenditures during the preceding income year.3

$$\text{RC Credit} = 20\% \times (\text{Current Year QREs} – \text{Prior Year QREs})$$

Connecticut’s formula is particularly favorable because it simplifies the calculation by defining the increment against the immediately preceding income year’s spending. Unlike some states or the federal regime which may utilize complex, historical base periods, Connecticut rewards nearly every dollar of incremental growth immediately.10 The 20% rate is considered one of the highest incremental rates offered nationally 10, positioning Connecticut as a highly desirable location for firms focused on rapid, sustained R&D expansion.

B. Utilization and Restriction

This credit provides a powerful incentive for firms undergoing rapid expansion, R&D mergers, or large-scale internal development projects. However, a crucial statutory restriction applies: a taxpayer cannot claim the incremental credit for the same research expenditures used to calculate the non-incremental credit in the same tax year.8 This mandates a strict segregation of Qualified Research Expenses (QREs) if a taxpayer attempts to utilize both methods simultaneously for different projects or categories of spending.

IV. Mechanism 2: Research and Development Expenses Tax Credit (The Non-Incremental RDC Credit)

The Non-Incremental RDC Credit (CGS § 12-217n) applies a rate to the total amount of R&D expenses incurred in Connecticut during the tax year, independent of prior year spending levels.11

A. Calculation for Large Corporations: The Graduated Tiered System

For corporations that do not qualify as Qualified Small Businesses (QSBs)—generally those with preceding year gross incomes above $100 million 11—the RDC Credit utilizes a tiered, progressive formula. This system structurally favors the state’s largest R&D investors by escalating the percentage rate only after significant spending thresholds are met.5

Table: Non-Incremental R&D Tax Credit (RDC) Tiered Structure (Non-QSBs)

Additionally, certain companies headquartered in an Enterprise Zone (EZ) that meet specific high-threshold criteria—such as employing more than 2,500 people and having annual revenues exceeding $3 billion—may elect an alternative rate. These companies can multiply their R&D expenses by 3.5% if that result is greater than the standard tiered calculation.4

B. Special Consideration for Qualified Small Businesses (QSBs)

The state offers significantly enhanced benefits to small and mid-sized companies defined as Qualified Small Businesses (QSBs), creating a distinct competitive advantage for these firms.

1. Definition and Eligibility Thresholds

A QSB is defined for RDC purposes as a business whose gross income for the preceding income year was $100 million or less.4

2. The Flat 6% Rate

QSBs benefit from a substantial incentive: they receive a flat 6% credit applied to their entire current-year research and development expenses.4 This provision is crucial because it allows QSBs to immediately access the highest non-incremental rate, bypassing the lower 1% and 2% tiers applicable to larger, non-QSBs. This policy decision strongly incentivizes mid-sized and emerging firms to maximize their R&D investment while their gross income remains below the $\$100$ million threshold. This specific distinction creates a substantial cliff-edge benefit, where a firm slightly below the $\$100$ million threshold receives significantly more credit value than one marginally over it.

V. Financial Mechanics: Carryforwards, Caps, and Refundability

The utility of the Connecticut R&D tax credit is determined by the rules governing how and when the credits can be monetized.

A. Utilization Limits Against Corporate Business Tax

The amount of R&D tax credits allowable in any given year is subject to a limitation based on the taxpayer’s Corporate Business Tax liability. Statutory changes have increased this ceiling over time.

For income year 2023 and thereafter, the maximum credit that may be applied against the tax due rose to 70% of the tax liability.3 Prior to this, the limit included 50.01% and 60% for income year 2022.3 It is important to note that the credits may only be applied against the tax liability; there is no automatic refund for any unused credits outside of the specific Qualified Small Business exchange program.12

B. Credit Carryforward Rules

For credits earned in tax years beginning on or after January 1, 2021, any unused tax credits can be carried forward for 15 successive income years until they are fully utilized.3 This 15-year carryforward provides substantial long-term certainty for companies facing utilization caps or periods of low profitability.

Credits generated in tax years prior to 2021 benefit from an even more generous rule, retaining an unlimited carryforward period.8 However, no carryback provision is permitted for either credit type.3 The simultaneous increase in the utilization cap (to 70%) and the codification of the 15-year carryforward period are linked policy actions. By increasing the annual utilization capacity, the state reduces the number of credits flowing into the carryforward stream, thereby managing its future tax obligations while still providing ample time for firms to realize the deferred benefit.

C. The QSB Exchange Option: Trading Credit for Cash

Connecticut offers a unique cash-generating mechanism for the smallest R&D firms, allowing them to exchange unused credits for a cash refund, mitigating the financial strain of pre-profitability R&D investment.

1. Eligibility for Refund

The exchange option is available exclusively to Qualified Small Businesses that meet a second, stricter size test 11:

• The business must be a QSB with gross income for the previous year less than $70 million.9
• The business must have unused credits and either zero or negative apportioned net income, or meet certain capital base tax thresholds, even if filing as part of a combined group on Form CT-1120CU.3

The existence of two separate gross income thresholds ($100 million for the 6% credit rate, $70 million for the 65% cash refund) demonstrates targeted policy layering. The 6% credit is designed to reward profitability up to $100 million, while the 65% cash refund mechanism is reserved for the smaller firms below $70 million that often need immediate working capital to sustain their initial R&D period.

2. The 65% Exchange Rate and Cap

Eligible QSBs can exchange their unused incremental and non-incremental credits with the state for 65% of their statutory value.12 The total cash refund available through this exchange is subject to an annual limit of $1,500,000 per tax year.11

3. Filing

The application for this exchange must be made using Form CT-1120 XCH, “Application for Exchange of Research and Development or Research and Experimental Expenditures Tax Credits by a Qualified Small Business,” filed with the DRS.9

VI. Comprehensive Case Study and Application Example

To illustrate the practical application of Connecticut’s R&D tax credits, particularly the highly advantageous incremental credit, the following analysis examines a multi-year scenario involving an aerospace component manufacturer. This firm has incurred significant R&D expenses but, due to its size, is subject to the tiered non-incremental rate.

A. Scenario Setup: Aerospace Component Manufacturer (Growth Phase)

The example firm is assumed to be a large taxpayer (Non-QSB) that experienced rapid growth in its Qualified Research Expenses (QREs) between 2018 and 2021.8

Table: Connecticut R&D Tax Credit Example Data (Aerospace Firm)

B. Detailed Calculation and Optimization Analysis (Focus on 2021)

This company must calculate its tentative credit under both the Non-Incremental (RDC) and Incremental (RC) methods to determine the most advantageous claim for 2021.

1. Non-Incremental RDC Calculation (CGS § 12-217n)

The RDC calculation applies a tiered rate to the total current-year QREs 5:

• QREs for 2021: $1,300,000.
• Rate: Since the QREs are below the $\$50$ million threshold, the Non-QSB rate is 1%.5
• RDC Credit: $\$1,300,000 \times 1\% = \mathbf{\$13,000}$

2. Incremental RC Calculation (CGS § 12-217j)

The RC calculation rewards the increase in QREs compared to the preceding year 3:

• Incremental QREs: $\$1,300,000$ (Current Year) $-\$900,000$ (Prior Year) $=\$400,000$.
• Rate: 20%.3
• RC Credit: $\$400,000 \times 20\% = \mathbf{\$80,000}$

3. Optimization and Utilization Strategy

The incremental credit calculation $(\$80,000)$ significantly exceeds the non-incremental credit $(\$13,000)$. The company would thus optimize its tax benefit by claiming the RC Credit (Incremental Method) for the QREs associated with its year-over-year growth component.

The case study data shows that the company only claimed $\$72,000$ in 2021.8 This suggests that the calculated tentative credit of $\$80,000$ was constrained by the statutory utilization cap.3 If the company had a Corporate Business Tax Liability (CBTL) of, for example, $\$120,000$ in 2021, and assuming the cap was 60% (a figure applicable around that period, moving toward the 70% threshold):

$$\text{Maximum Utilization} = \text{CBTL} \times \text{Utilization Cap}$$

$$\text{Maximum Utilization} = \$120,000 \times 60\% = \mathbf{\$72,000}$$

This confirms that the claimed credit amount was likely limited by the state’s utilization cap, a key consideration for high-growth R&D firms that may generate credits faster than they can use them. The remaining $\$8,000$ in unused tentative credit $(\$80,000 – \$72,000)$ would then be carried forward for up to 15 successive income years.3 If a firm consistently encounters this utilization ceiling, it may eventually accumulate over $\$500,000$ in stranded credits, making it a candidate for the DECD’s Accumulated Tax Credit Expansion Program (ATCEP).1

Conclusion: Navigating Compliance and Maximizing Connecticut R&D Investment

Connecticut maintains an aggressive and highly competitive R&D tax incentive landscape, structured around two distinct statutory credits administered by the DRS and augmented by strategic economic development intervention by the DECD.

For corporations, strategic tax planning must focus on two primary objectives: maximizing the calculation and managing the utilization. Firms undergoing rapid expansion are best positioned to leverage the 20% incremental rate (RC Credit), which provides one of the highest returns on new R&D spending nationally. Smaller, emerging firms that qualify as a Qualified Small Business (gross income $\le \$100$ million) should utilize the superior 6% flat rate on total R&D expenses (RDC Credit). Furthermore, the 65% cash refund option, reserved for the smallest QSBs (gross income $\le \$70$ million) up to a $\$1.5$ million annual cap, is a vital mechanism for converting tax assets into immediate working capital.

Compliance requires rigorous adherence to DRS guidance, including the recognition that the non-incremental credit’s definition of QREs is fixed to 1993 federal law, necessitating independent expense tracking. Finally, firms generating significant credits must proactively manage the 70% utilization cap against the Corporation Business Tax liability. When tax credits become “stranded” (over $\$500,000$ and unused for two years), the DECD’s ATCEP provides a unique avenue to monetize these assets in exchange for a binding commitment to generate new jobs or capital expenditures of at least $\$5$ million. Effective navigation of the Connecticut R&D tax landscape requires expert knowledge of both the DRS’s compliance framework and the DECD’s performance-based economic programs.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/